美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Baillie Gifford International Alpha ETF

25.19

+0.28521.15%

盤後：25.190.00000.00%16:10 EDT

成交量：6,316

成交額：15.92萬

市值：3.28億

市盈率：- -

高：25.21

開：25.20

低：25.19

收：24.90

52周最高：25.97

52周最低：23.97

股本：1,301.20萬

流通股本：1,301.20萬

量比：0.72

換手率：0.05%

股息：- -

股息率：- -

淨資產收益率：--

總資產收益率：--

市淨率：--

市盈率(LYR):- -

資料載入中...

總覽公司新聞資訊公告

美股收盤｜英特爾漲7.67%，AMD 6.36%，美光科技與台積電提振半導體

諾和諾德：預計降糖藥Frehemgo將於2026年第四季度在歐洲推出，2027年初實現全歐盟範圍上市。

諾和諾德：歐洲藥品管理局人用醫藥產品委員會建議歐盟批准 Frehemgo®，這是首款可每月給藥的凝血因子 VIII 模擬

Orbis Medicines與諾和諾德達成14億美元藥物合作協議

諾和諾德：DeneciMig 在從依庫珠單抗轉換用藥後展現良好耐受性。

諾和諾德稱研究未發現意外安全風險。

阿斯麥美股盤前升逾2%

諾和諾德攜手Anthropic 以AI加速藥物研發

环球市场播报

諾和諾德、禮來、字節系落子AI製藥，A股創新藥、CRO板塊嗨了

华尔街见闻

諾和諾德跨界合作Anthropic，AI製藥股走強，百普賽斯漲近15%

諾和諾德攜手Anthropic，利用AI加速藥物研發

TradingKey中文

美股異動丨諾和諾德盤前升逾1% 將與Anthropic合作推進藥物研發

諾和諾德與Anthropic將合作使用Claude推進藥物研發

諾和諾德與Anthropic將合作推進藥物研發，諾和諾德將使用Claude輔助研發工作流程。

諾和諾德(NVO.US)盤前拉升升逾1%，公司將與Anthropic合作推進藥物研發。

諾和諾德將使用Claude Science開展研發工作流。

諾和諾德與Anthropic開展合作，藉助Claude推進藥物研發。

市場消息：諾和諾德(NVO.US)與Anthropic將合作推進藥物研發。

諾和諾德(NVO.US)首席執行官：諾和諾德需要擴大其業務範圍以應對未來挑戰。

美國口服減肥藥競爭升級！禮來(LLY.US)Foundayo搶下三成新患者，諾和諾德(NVO.US)先發優勢收窄

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/hant/stock/BGIA/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BGIA","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BGIA\",,,,,undefined,":{"symbol":"BGIA","market":"US","secType":"STK","nameCN":"Baillie Gifford International Alpha ETF","latestPrice":25.1852,"timestamp":1789675200000,"preClose":24.9,"halted":0,"volume":6316,"hourTrading":{"tag":"盘后","latestPrice":25.1852,"preClose":25.1852,"latestTime":"16:10 EDT","volume":6,"amount":151.1112,"timestamp":1789675803858,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.011453815261044165,"floatShares":13012033,"shares":13012033,"eps":0,"marketStatus":"盤後交易","change":0.2852,"latestTime":"09-17 17:01:53 EDT","open":25.2,"high":25.21,"low":25.1852,"amount":159194,"amplitude":0.000996,"askPrice":37.75,"askSize":200,"bidPrice":12.59,"bidSize":200,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":3,"nextMarketStatus":{"tag":"收盤","tradingStatus":0,"beginTime":1789689600000},"marketStatusCode":4,"adr":0,"exchange":"NASDAQ","adjPreClose":24.9,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":25.1852,"preClose":25.1852,"latestTime":"16:10 EDT","volume":6,"amount":151.1112,"timestamp":1789675803858,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.718936},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BGIA\",,,,,undefined,":{"symbol":"BGIA","floatShares":13012033,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.718936,"shares":13012033,"dividePrice":0,"high":25.21,"amplitude":0.000996,"preClose":24.9,"low":25.1852,"week52Low":23.9707,"pbRate":"--","week52High":25.97,"institutionHeld":0,"latestPrice":25.1852,"eps":0,"divideRate":0,"volume":6316,"delay":0,"ttmEps":0,"open":25.2,"prevYearClose":25.2,"prevWeekClose":25.3728,"prevMonthClose":25.6781,"prevQuarterClose":24.4419,"fiveDayClose":25.2,"twentyDayClose":25.4439,"sixtyDayClose":24.3358},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BGIA\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BGIA\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"BGIA\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BGIA\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1178825473","title":"美股收盤｜英特爾漲7.67%，AMD 6.36%，美光科技與台積電提振半導體","url":"https://stock-news.laohu8.com/highlight/detail?id=1178825473","media":"美股收盘","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1178825473?lang=zh_tw&edition=fundamental","pubTime":"2026-09-18 04:00","pubTimestamp":1789675251,"startTime":"0","endTime":"0","summary":"道琼斯收涨0.61%，标普500上涨1.14%，纳斯达克领涨1.69%。在美联储加息落地后，投资者对经济韧性与企业盈利的信心回升，科技与半导体板块成为推升指数的核心力量。热门股异动：半导体龙头集体走强，美国超微公司劲升6.36%，英特尔大涨7.67%，美光科技攀升5.50%，英伟达续涨2.54%，迈威尔科技跳升4.81%；特斯拉上涨2.27%，苹果小幅走高1.38%。中标收益率显著高于二级市场，投标倍数下滑至2.24，显示需求降温同时反映投资者对通胀与财政赤字前景的担忧。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2403377893.USD","LU0048584097.USD","LU1778281490.HKD","LU2211814178.USD","LU1674673428.USD","WISE","AIFD","LU0541501648.USD","LU0541502299.USD","LU0256863902.USD","LU0289960550.SGD","LU2168564149.EUR","BK4526","LU0889565833.HKD","LU1868838027.USD","UMMA","LU1623119135.USD","IE00BSNM7G36.USD","SOXQ","LU0792757196.USD","LU0238689110.USD","LU0234570918.USD","IE0004445239.USD","LU0157215616.USD","LU2054465674.USD","LU0097036916.USD","LU2106854487.HKD","LU2360032135.SGD","CNEQ","LU2458330169.SGD","LU0572939691.SGD","TSMG","WUGI","BAI","LU0359201612.USD","159582","TEKX","EWT","ARTY","LU2213496289.HKD","SOXY","MUG","LU1803068979.SGD","LU1023057109.AUD","FWD","LU1989764748.USD","FLTW","LU1242518931.SGD","LU2237443382.USD","EMC","LU0820561909.HKD","LU0943347566.SGD","LU0672654240.SGD","AMDU","LU0689472784.USD","LU1861559042.SGD","IE00BKVL7J92.USD","EMSF","CORO","LU0823421333.USD","BK4512","IE000SO60NU8.SGD","LU2089985449.USD","AMDS","LU0251132253.USD","SINTCmain","EIS","LU2462591350.SGD","AIS","LU0359201885.HKD","LU1917777945.USD","TWSC","MUYY","TECY","LU1242518857.USD","TWN","LU0211328371.USD","CWI","TSM","LU2041044095.USD","LU2108987350.USD","CHPY","MUU","LU0143863198.USD","LU2491049909.HKD","HBMX","IE000BZT7R73.USD","LU2092937221.SGD","LU2242649171.HKD","LU2361044865.SGD","LU2168563687.JPY","IE0002270589.USD","IE00BKDWB100.SGD","LU1852331112.SGD","IE0009356076.USD","IE00BHPRN162.USD","LU0321505439.SGD","SOXS","ESIM","LU0124676726.USD","LU1282649810.SGD","TEK","LU0061475181.USD","LU0787776722.HKD","TSMU","LU0149725797.USD","AVEM","LU1974910355.USD","LU0823434740.USD","SMH","TSMY","LU2764263203.CNY","LU0823414478.USD","BK4566","IE00BMPRXR70.SGD","INTC","LU1316542783.SGD","LU1323610961.USD","BK4605","CHPX","IE00BQXX3F31.USD","IE00B1BXHZ80.USD","LU0979878070.USD","FDTX","IE00B7SZLL34.SGD","LU0823434583.USD","IE00B5TLWC47.USD","DAMD","LU1037948897.HKD","LU0310799852.SGD","LU2286300806.USD","MULL","LU2860962120.EUR","BK4532","LU2236285917.USD","IE0004086264.USD","IE00B3M56506.USD","LU1861215975.USD","NBDS","LU0174119429.USD","LU0203347892.USD","LU2211815571.USD","SG9999004220.SGD","BK4553","LU0823414551.USD","LU1988902786.USD","LU0211327993.USD","LU2756315318.SGD","LU0786609619.USD","LU1934455863.HKD","SHOC","LU2023250504.SGD","LU0096364046.USD","BK4581","LU0820562030.AUD","SGXZ81514606.USD","LU0056508442.USD","CHPS","LU0683600562.USD","BK4515","ILDR","IE00BQXX3C00.GBP","BK4612","LU1868836591.USD","AMDL","LU0158827781.USD","MUZ","IE00B19Z3581.USD","LU1951198990.SGD","SMU00main","LU0321505868.SGD","LU2265009873.SGD","SG9999000418.SGD","AMYY","LU2294711713.HKD","AMDD","LU0965509010.AUD","LU0251142724.SGD","LU0082616367.USD","LU2471134523.USD","LU2756315664.SGD","BK4534","LU1551013425.SGD","LU0143863784.USD","LU2361044949.HKD","LU2471134952.CNY","BK4543","LU0048573561.USD","XSD","LU2355687059.USD","LU2125154935.USD","IEMG","MQQQ","LU2237443622.USD","LU2357305700.SGD","LU2360106780.USD","LU0742534661.SGD","LU2750360997.AUD","IE00BMPRXQ63.HKD","LU0345770993.USD","LU0390134368.USD","LU1868836757.USD","RULE","MUD","XLK","LU2896262040.SGD","IE000MB6IJN5.SGD","LU2098885051.SGD","IE00BQXX3D17.EUR","LU1366333091.USD","WLDR","SAMD0main","LU0210536198.USD","LU0175139822.USD","ASIA","LU1914381329.SGD","LU2264538146.SGD","LU1880398554.USD","LU0109391861.USD","AVSE","BGIA","LU1508157978.USD","LU2471134879.HKD","FAI","TTXU","SSG","AMDY","USXF","LU0965509101.SGD","LU0251131958.USD","LU2237443549.SGD","PSI","LU0689626769.HKD","AIQ","LU2168564222.USD","KNOW","BK4550","BK4504","ADVE","AMUU","IETC","LU2458330243.SGD","IE00BMPRXN33.USD","LU0417517546.SGD","CNAV","LU1868837136.USD","JGRO","DRMY","LU0861579265.USD","LU1037948541.HKD","LU0708995401.HKD","LU2244417387.USD","LU1280957306.USD","LU1303367103.USD","LU0882747503.HKD","LU1923623000.USD","SMHU","LU1551013342.USD","BK4554","LU1868837565.USD","LU1267930490.SGD","LU1548497426.USD","LU1861220033.SGD","MEMX","LU1989764664.SGD","LU2148611432.USD","BOBP","IE0001KFT4U8.USD","IE0004091025.USD","03145","LU1629891620.HKD","LU1880398471.USD","LU0965509283.SGD","QQQA","LU0133085943.USD","LU2417539215.USD","LU2089284900.SGD","LU0964807845.USD","LU1868836914.USD","LU1934455194.USD","LU2023250330.USD","LU2720916845.USD","TSMX","LU0127658192.USD","IE00BK4W5L77.USD","SPTE","GFSG","LU2271345857.HKD","BK4533","LU1211504680.USD","GFS","IE00BWXC8680.SGD","LU1861558580.USD","LU0274383776.USD","AMD","LINT","LU2931357623.SGD","LU1267930813.SGD","LU2361045086.USD","IE0034235303.USD","AVXC","EFIV","BK4614","SG9999001424.SGD","LU1934455277.USD","LU1267930730.SGD","LU2133065610.SGD","LU2471134796.USD","LU0642271901.SGD","LU0719512351.SGD","XNTK","FTEC","LU1868837300.USD","LU0889566641.SGD","LU2461242641.AUD","SOXL","AMDC","AMDG","BK4505","SGXZ99366536.SGD","LU0264606111.USD","LU1048588211.SGD","EMM","LU0320765059.SGD","BK4585","FTXL","BK4588","IE000F7OJYX1.SGD","LU2249611893.SGD","LU2764263039.SGD","CWC","LU2250418816.HKD","IE00BK4W5M84.HKD","LU0878004406.USD","PTF","LU0094547139.USD","LU1868837722.USD","CGIC","LU0198837287.USD","INTW","LU1064131342.USD","USD","LU2125154778.USD","CGDG","LU0323591593.USD","LU1145028129.USD","LU1720051108.HKD","LU0316494557.USD","EMXC","IE0000B7K699.USD","LU2168564065.EUR","LU2102340556.USD","LU2290526834.HKD","BK4535","LU1951200564.SGD","LU1232071149.USD","LU0823421416.USD","DRIV","LU2491050071.SGD","BK4579","IE00BJLML261.HKD","BK4602","CHAT","LU1804176565.USD","LU2456880835.USD","LU0072462343.USD","IE00BZ1G4Q59.USD","LU0158827948.USD","IXN","LU2360108059.USD","TTEQ","EGGY","LU2063271972.USD","TSMZ","LU0187121727.USD","LU2750360641.GBP","LU1282649067.USD","BK4503","IE00BZ199S13.USD","IE00B5949003.HKD","LU2298321311.HKD","VGT","LU0572940350.SGD","HK0000304797.USD","LU0203345920.USD","DISK","BLOX","SOXX","LEGR","HK0000304805.HKD","LU2543165471.USD","MU","LU0859254822.USD","BK4573","LU0353189763.USD","LU2360107168.USD","LU2663582299.SGD","LU2089283258.USD","LU1989772923.USD","LU2168564495.EUR","BK4548","AMDW","LU1712237335.SGD","LU0965508806.USD","LU0109392836.USD","SMHX","LU0878005551.USD","LU0488056044.USD","LU2237443978.SGD","BK4591","TRFK","LU0359202008.SGD","IE00BKPKM429.USD","MIC","LU0384037296.USD","GB00BDT5M118.USD","CGNG","IE00B1XK9C88.USD","LU1674673691.USD","LU0256863811.USD","LU0348723411.USD","LU0820561818.USD","BK4575","LU2028103732.USD","LU2357627491.SGD","STSM","LU2023251221.USD","LU2087625088.SGD","IE00BD6J9T35.USD","IE000M9KFDE8.USD","LU1720051017.SGD","SGXZ51526630.SGD","BK4529","IE000WAW04H5.SGD","LU2247934214.USD","INT","SPWO","CGGO","LU2048586759.USD","INYY","EDZ","LU2491050154.USD","LU2764262908.HKD","LU0353189680.USD","GAMR","LU0640476718.USD","BK4141","BK4527","LU0154236417.USD","LU2111349929.HKD","LU0345770308.USD","LU0081259029.USD","FXL","IE00B19Z3B42.SGD","LU1989772840.SGD","LU2357125470.USD","TINS","LU2506951792.HKD","IE00BFXG0V08.USD","IE00BYQQ9H92.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668772998","title":"諾和諾德：預計降糖藥Frehemgo將於2026年第四季度在歐洲推出，2027年初實現全歐盟範圍上市。","url":"https://stock-news.laohu8.com/highlight/detail?id=2668772998","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668772998?lang=zh_tw&edition=fundamental","pubTime":"2026-09-17 22:15","pubTimestamp":1789654521,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BGIA","IPOS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668708998","title":"諾和諾德：歐洲藥品管理局人用醫藥產品委員會建議歐盟批准 Frehemgo®，這是首款可每月給藥的凝血因子 VIII 模擬","url":"https://stock-news.laohu8.com/highlight/detail?id=2668708998","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668708998?lang=zh_tw&edition=fundamental","pubTime":"2026-09-17 22:15","pubTimestamp":1789654514,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BGIA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668960641","title":"Orbis Medicines與諾和諾德達成14億美元藥物合作協議","url":"https://stock-news.laohu8.com/highlight/detail?id=2668960641","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668960641?lang=zh_tw&edition=fundamental","pubTime":"2026-09-17 21:21","pubTimestamp":1789651296,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BGIA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668969428","title":"諾和諾德：DeneciMig 在從依庫珠單抗轉換用藥後展現良好耐受性。","url":"https://stock-news.laohu8.com/highlight/detail?id=2668969428","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668969428?lang=zh_tw&edition=fundamental","pubTime":"2026-09-17 19:06","pubTimestamp":1789643179,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BGIA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668694449","title":"諾和諾德稱研究未發現意外安全風險。","url":"https://stock-news.laohu8.com/highlight/detail?id=2668694449","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668694449?lang=zh_tw&edition=fundamental","pubTime":"2026-09-17 19:05","pubTimestamp":1789643157,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BGIA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668963556","title":"阿斯麥美股盤前升逾2%","url":"https://stock-news.laohu8.com/highlight/detail?id=2668963556","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668963556?lang=zh_tw&edition=fundamental","pubTime":"2026-09-17 17:31","pubTimestamp":1789637508,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BGIA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668406952","title":"諾和諾德攜手Anthropic 以AI加速藥物研發","url":"https://stock-news.laohu8.com/highlight/detail?id=2668406952","media":"环球市场播报","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668406952?lang=zh_tw&edition=fundamental","pubTime":"2026-09-17 15:49","pubTimestamp":1789631340,"startTime":"0","endTime":"0","summary":"诺和诺德表示，将测试Claude Science以帮助解决科学问题，并计划使用Anthropic的模型加强AI驱动的软件开发。一些AI发现的候选药物正在人体试验，但AI尚未产生获批药物。AI还用于识别可参与药物研究的患者。诺和诺德此前已达成多项合作，旨在通过AI加速新药发现与开发。诺和诺德发言未提供交易条款或可能针对的药物发现项目具体细节。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2026-09-17/doc-iniscksh9276349.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["IBBJ","QTOC","ARTY","AIPO","AGIX","VTHR","BGIA","CHAT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668518799","title":"諾和諾德、禮來、字節系落子AI製藥，A股創新藥、CRO板塊嗨了","url":"https://stock-news.laohu8.com/highlight/detail?id=2668518799","media":"华尔街见闻","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668518799?lang=zh_tw&edition=fundamental","pubTime":"2026-09-17 14:26","pubTimestamp":1789626360,"startTime":"0","endTime":"0","summary":"诺和诺德与Anthropic达成AI合作，金斯瑞携手礼来TuneLab平台提供湿实验验证，字节拆分的Anew Labs亦获2.9亿美元融资。多重重磅合作与融资密集落地，显现AI制药协作热潮，带动A股创新药、CRO板块大涨。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"6e7a4338b1034ad785d5025385d8625c","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://wallstreetcn.com/articles/3781972","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1147","BK1574","03130","07233","ARTY","CHAT","VTHR","BK1191","02827","83188","LNGR","83130","01477","MEDX","06978","159992","BGIA","IBBQ","159982","82846","QTOC","399300","AIPO","BK1161","AGIX","03188","02846"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668793089","title":"諾和諾德跨界合作Anthropic，AI製藥股走強，百普賽斯漲近15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2668793089","media":"格隆汇","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668793089?lang=zh_tw&edition=fundamental","pubTime":"2026-09-17 09:44","pubTimestamp":1789609455,"startTime":"0","endTime":"0","summary":"9月17日，A股市场AI制药股集体上涨，其中，百普赛斯涨近15%，泓博医药涨7%，协创数据涨超5%，华大智造涨超3%，华兰股份、贝瑞基因、百奥赛图涨近3%。消息面上，诺和诺德与Anthropic宣布达成合作，双方将利用Anthropic的人工智能(AI)模型及Claude Science支持药物发现与研发。\n\n港股频道更多独家策划、专家专栏，免费查阅>>\n\n            责任编辑：栎树","market":"sh","thumbnail":"http://imgcloud.jrjimg.cn/2026/09/cms_20260917094415461.jpg","type":0,"news_type":0,"thumbnails":["http://imgcloud.jrjimg.cn/2026/09/cms_20260917094415461.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2026/09/17094458468069.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BGIA","QTOC","ARTY","AIPO","BK1191","BK0216","01477","301080","BK1574","CHAT","AGIX","VTHR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667978986","title":"諾和諾德攜手Anthropic，利用AI加速藥物研發","url":"https://stock-news.laohu8.com/highlight/detail?id=2667978986","media":"TradingKey中文","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667978986?lang=zh_tw&edition=fundamental","pubTime":"2026-09-16 21:21","pubTimestamp":1789564891,"startTime":"0","endTime":"0","summary":"TradingKey - 9月16日，诺和诺德（NVO）宣布与人工智能公司Anthropic达成合作，将利用Claude及相关AI模型支持药物研发，并进一步推进人工智能在科学研究和软件开发领域的应用。","market":"sh","thumbnail":"https://resource.tradingkey.com/uploads/20260204/novo-097495ca9dea48fc8abd9bbb031282c3.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/uploads/20260204/novo-097495ca9dea48fc8abd9bbb031282c3.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/zh-hans/analysis/stocks/us-stock/262170963-novo-nordisk-partners-anthropic-accelerate-drug-discovery-using-ai-tradingkey","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CHAT","VTHR","BGIA","AIPO","QTOC","AGIX","IBBJ","ARTY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667983620","title":"美股異動丨諾和諾德盤前升逾1% 將與Anthropic合作推進藥物研發","url":"https://stock-news.laohu8.com/highlight/detail?id=2667983620","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667983620?lang=zh_tw&edition=fundamental","pubTime":"2026-09-16 20:24","pubTimestamp":1789561486,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["IBBJ","BGIA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667983187","title":"諾和諾德與Anthropic將合作使用Claude推進藥物研發","url":"https://stock-news.laohu8.com/highlight/detail?id=2667983187","media":"第一财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667983187?lang=zh_tw&edition=fundamental","pubTime":"2026-09-16 20:15","pubTimestamp":1789560905,"startTime":"0","endTime":"0","summary":"【诺和诺德与Anthropic将合作使用Claude推进药物研发】据诺和诺德官网消息，诺和诺德与Anthropic将合作推进药物研发，诺和诺德将使用Claude辅助研发工作流程。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202609163876227697.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202609163876227697.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BGIA","IBBJ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667988768","title":"諾和諾德與Anthropic將合作推進藥物研發，諾和諾德將使用Claude輔助研發工作流程。","url":"https://stock-news.laohu8.com/highlight/detail?id=2667988768","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667988768?lang=zh_tw&edition=fundamental","pubTime":"2026-09-16 20:08","pubTimestamp":1789560535,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BGIA","IBBJ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667988257","title":"諾和諾德(NVO.US)盤前拉升升逾1%，公司將與Anthropic合作推進藥物研發。","url":"https://stock-news.laohu8.com/highlight/detail?id=2667988257","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667988257?lang=zh_tw&edition=fundamental","pubTime":"2026-09-16 20:01","pubTimestamp":1789560102,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BGIA","IBBJ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667102988","title":"諾和諾德將使用Claude Science開展研發工作流。","url":"https://stock-news.laohu8.com/highlight/detail?id=2667102988","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667102988?lang=zh_tw&edition=fundamental","pubTime":"2026-09-16 20:00","pubTimestamp":1789560053,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BGIA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667988109","title":"諾和諾德與Anthropic開展合作，藉助Claude推進藥物研發。","url":"https://stock-news.laohu8.com/highlight/detail?id=2667988109","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667988109?lang=zh_tw&edition=fundamental","pubTime":"2026-09-16 20:00","pubTimestamp":1789560027,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["IBBJ","BGIA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667988100","title":"市場消息：諾和諾德(NVO.US)與Anthropic將合作推進藥物研發。","url":"https://stock-news.laohu8.com/highlight/detail?id=2667988100","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667988100?lang=zh_tw&edition=fundamental","pubTime":"2026-09-16 20:00","pubTimestamp":1789560026,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BGIA","IBBJ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667406476","title":"諾和諾德(NVO.US)首席執行官：諾和諾德需要擴大其業務範圍以應對未來挑戰。","url":"https://stock-news.laohu8.com/highlight/detail?id=2667406476","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667406476?lang=zh_tw&edition=fundamental","pubTime":"2026-09-15 21:23","pubTimestamp":1789478634,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BGIA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667618217","title":"美國口服減肥藥競爭升級！禮來(LLY.US)Foundayo搶下三成新患者，諾和諾德(NVO.US)先發優勢收窄","url":"https://stock-news.laohu8.com/highlight/detail?id=2667618217","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667618217?lang=zh_tw&edition=fundamental","pubTime":"2026-09-15 11:02","pubTimestamp":1789441373,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，礼来周一表示，其口服减肥药Foundayo已在美国口服肥胖症治疗市场的新增患者中占据超过30%的份额，缩小了丹麦竞争对手诺和诺德凭借其Wegovy口服片剂所取得的早期领先优势。据了解，礼来的口服减肥药Foundayo于4月初上市，比诺和诺德的竞品Wegovy口服片晚了约三个月。诺和诺德在1月表示，预计到2030年，口服药物将占GLP-1减肥治疗使用量的三分之一以上。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1496046.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["THNR","BGIA"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":7,"pageCount":1,"totalSize":132,"code":"91000000","status":"200"}]}}